If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
Description
Anti-Human CTLA4 Therapeutic Antibody (Yervoy). Recombinant monoclonal antibody to CTLA4. Ipilimumab (known as MDX-010 and MDX-101), marketed as Yervoy, is a drug used for the treatment of melanoma, a type of skin cancer. It is a U.S. Food and Drug Administration (FDA) approved human monoclonal antibodSuitable for use in ELISA, IP, FC, FuncS, Neut, IF and most other immunological methods.
Immunogen
n/a
Other Names
Ipilimumab;yervoy;477202-00-9;MDX-010;MDX-101;Yervoy;MDX-010;MDX-101;CTLA4;cytotoxic T-lymphocyte-associated protein 4;celiac disease 3 , CELIAC3;cytotoxic T-lymphocyte protein 4;CD;CD28;CD152;GSE;ICOS;CD152 isoform;celiac disease 3;cytotoxic T-lymphocyte